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was considered a success, with producers encountering few additional costs. When the country further
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costs. In addition, a complete ban actually increased the total antibiotics used, as Danish veterinarians were
forced to prescribe additional therapeutic agents—and prescribed those used most often in human medicine.
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Executive Summary 
McDonald's Corporation, one of the largest buyers of meat in the U.S. fast-food 
industry, recently adopted a policy that prohibits its direct suppliers from using medically 
important antibiotics as growth promotants in food animals after 2004. Although the 
implications of such a voluntary ban in the United States remain to be seen, recent 
experiences in Denmark provide some comparable evidence on the effects for hog 
production. An economic analysis, compiled from information gleaned from interviews 
with Danish veterinarians, farmers, economists, and industry analysts, estimates the 
economic costs of an antibiotics ban on pork producers in the United States. Denmark 
first imposed a ban in pork production at the finishing stage, which was considered a 
success, with producers encountering few additional costs. When the country further 
implemented a ban at the weaning stage, producers encountered severe health problems 
and incurred large costs. In addition, a complete ban actually increased the total 
antibiotics used, as Danish veterinarians were forced to prescribe additional therapeutic 
agents—and prescribed those used most often in human medicine. The economic analysis 
of U.S. hog production indicates that a U.S. ban would increase costs by approximately 
$4.50 per animal in the first year. The total cost of a ban to the U.S. pork industry spread 
across a ten-year period could be in excess of $700 million.  
 
Keywords: antibiotics, economic costs of regulation, food safety, pork production.
  
 
 
LESSONS FROM THE DANISH BAN ON FEED-GRADE ANTIBIOTICS 
 
 
In June of 2003, McDonald’s Corporation announced that it would prohibit its direct 
suppliers from using antibiotics that are important in human medicine as growth 
promoters in food animals after 2004. The company also created a purchasing preference 
for companies that work to minimize antibiotic use. This announcement, coupled with 
recent Food and Drug Administration guidance on the same issue, will put pressure on 
the U.S. livestock industry to consider alternatives to feed-grade antibiotics. Denmark 
recently banned the use of feed-grade antibiotics in pork production and has been joined 
in this action by countries in the European Union. The ban was implemented first at the 
finishing stage and then at the weaning stage. Here, we describe Denmark’s experiences 
with the withdrawal of antibiotics from feed. 
In summary, the Danes achieved a large reduction in antibiotic use, and producers 
encountered few costs when they banned at the finishing stage. However, when they 
imposed a ban at the weaning stage they encountered severe health problems and 
incurred large costs. Generally speaking, they achieved 80 percent of the benefits for 20 
percent of the costs when they imposed a partial ban and encountered 20 percent of the 
benefits and 80 percent of the costs when they extended the ban.  
The health consequences of the complete ban were so severe that veterinarians were 
forced to prescribe additional therapeutic antibiotics, which resulted in an increase in 
total antibiotic use. In addition, the antibiotics that the Danish veterinarians prescribed 
were those that are often used in human medicine, whereas the antibiotics that were 
banned are not. The country is now grappling with an increased resistance to these 
antibiotics in their population. This is a classic example of how a policy prescription can 
have consequences that are exactly the opposite of those intended.  
Here, we describe the changes that were implemented in Denmark and the ways in 
which the Danish pork industry responded to these changes as we observed them in 
Denmark and through discussions with Danish veterinarians, farmers, economists, and 
industry analysts. We focus on the economic impact of the ban, as well as on the total 
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antibiotic consumption, and use the evidence to consider the likely economic impacts of a 
similar ban for U.S. pork producers. 
 
Background 
Current E.U. regulations restrict the use of antimicrobials—derived from either 
human or veterinary therapeutic medicine—as feed-additive growth promoters in 
livestock. The European Union currently restricts the list of approved feed additives to 
include only avilamycin, bambermycin, salinomycin, and monensin, and these antibiotic 
growth promotants (AGPs) are scheduled to be banned by 2006. 
The Danish government instituted a voluntary ban on the use of AGPs in pork 
production at the finishing stage in 1998 (accompanied by a penalty tax for use). On 
January 1, 2000, they banned AGPs at both the weaning and finishing stages. Denmark 
provides a suitable market for evaluating the cost impact of a ban of AGPs. It is an 
export-oriented and market-driven production system. It maintains excellent records on 
production costs and on antibiotic use, and its pork industry is at least as sophisticated as 
that of the United States.  
 
Antibiotic Use 
As shown in Figure 1 (based on data from DANMAP 2001; see DVI 2002), 
Denmark’s total consumption of antibiotics in pork production was 152 metric tons (mt) 
of active ingredient in 1996, 106 mt of AGPs, and 48 mt of therapeutic use as medication. 
By 1998 when antibiotics were banned from use at the finishing stage, the total use was 
106 mt. AGP use fell by about 50 percent (from 107 mt to 49 mt) and therapeutic use 
remained about constant. By 1999, overall antibiotic use fell to a low of 74 mt. 
The effective ban of AGPs at the finishing stage in 1998 was accomplished through a 
tax and some pressure to discontinue the use of subtherapeutic antibiotics. Danish farm 
management experts calculated the economic value of the subtherapeutic antibiotics at 
the finishing stage. Based on their estimates, farmers were required to pay a tax of $2.00 
per head on animals for which the products were used or to agree to discontinue use. 
Policymakers considered this level of tax “about right.” Faced with this tax, most 
producers stopped using the products at the finishing stage. Farmers reported very few  
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Source: DANMAP 2000 (DVI 2001); DANMAP 2001 (DVI 2002). 
FIGURE 1. Total consumption of antibiotics in Denmark (mt of active ingredients) 
 
health problems in their herds, a result that indicates that most of the benefits of AGP use 
at the finishing stage were driven by a growth-promoting effect plus a small reduction in 
mortality. National mortality did increase from 3 to 3.6 percent in 1999, but it is not clear 
that any of this was due to the ban. The Danes viewed the ban at the finishing stage as a 
resounding success. Total antibiotic use was cut by more than 50 percent, and very few 
health problems were encountered. 
The ban at the weaning stage in 2000 was much more difficult for farmers; they reported 
some severe health problems, especially in the early stages of pig production (National 
Committee for Pig Production 2002). Producers responded by restricting feed for the first two 
weeks. As problems of piglet mortality and disease mounted, veterinarians became more 
dependent on the use of therapeutic antibiotics. As a result, although the use of AGPs fell to 
nearly zero in 2000, the use of antibiotics as therapeutic medications increased. Therapeutic 
medications were increasingly substituted for the now-banned AGPs. Thus, the consumption 
of total antibiotics increased from 74 mt in 1999 to 81 mt in 2000 and to 94 mt in 2001. 
Despite this increase, the overall level of antibiotic use in 2001 was still limited to about 60 
percent of the level used in 1996 before the ban at the finishing stage. On a per pig basis, the 
level in 2001 was estimated to be 3.0 grams per pig, down from earlier levels (DVI 2002). 
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Most of the pig health problems experienced after the ban were described as 
problems with post-weaning diarrhea and also some diarrhea at the finishing stage. The 
Danish producers and veterinarians we spoke with reported that the pigs were weaker and 
more vulnerable to disease when they were moved to the finishing barns. The Danish 
experience suggests that reduced use of antibiotics at the weaning stage has had 
significant animal health effects throughout the production system. 
 
Future Patterns of Antibiotic Use in Denmark 
The Danes have implemented a major effort to track antibiotic resistance in animal 
bacterial isolates through DANMAP, the Danish Integrated Antimicrobial Resistance 
Monitoring and Research Programme. Through a parallel program called VetStat, the 
Danes are able to monitor the prescription of antibiotics by type of antibiotic, by farm, 
and by veterinarian because of unique features of their prescription issuance and 
reporting system. According to the veterinarians interviewed, this reporting system has 
provided the ability to use prescription information to identify veterinarians and quantify 
the use of antibiotics in each swine herd. Through the use of this and other controls, the 
national authorities have confidence that they can further reduce the overall use of 
antibiotics and that they have the tools to do so.  
 
Human Health Impacts and the Law of Unintended Consequences 
Although human health impacts were not the focus of our study, we should point out 
that the AGP products that were banned in Denmark have less use in human medicine 
than do the therapeutic antibiotics that replaced them. Table 1 shows the large increase in 
the use of human health products such as tetracyclines, penicillins, and macrolides in 
Danish food animal production.  
We could reasonably conclude that the use of the human health products in animal 
production might be more harmful to human health than the products they replaced. This 
logic is supported by evidence from human health studies in Denmark. Of particular 
concern is the increase in antimicrobial resistance among Salmonella typhimurium and 
Campylobacter jejuni human isolates to tetracycline and other selected antimicrobials in 
Denmark in 2001 (Figure 2). This evidence is important because the antibiotics that were
  
 
TABLE 1. Trends in the estimated total usage of antimicrobials for treatment of food animals in Denmark (kg active 
compound) 
ATC Group Compound 1986 1988 1990 1992 1994 1996 1998 1999 2000 2001a 
J01A Tetracyclines 3,800 3,600 9,300 22,000 36,500 12,900 12,100 16,200 24,000 27,900 
J01C Penicillins 3,700 3,800 5,000 6,700 9,400 7,200 14,300 14,700 14,800  17,100 
 with narrow  
 spectrum  
J01C/J01D Penicillins 850 1,000 1,200 2,500 4,400 5,800 6,700 6,600 7,600  9,300 
 with extended  
 spectrum 
J01E Sulfonamides 2,500 2,200 3,800 7,900 9,500 4,800 7,700 6,800 7,000  7,400 
 + trimethoprim 
J01E Sulfonamides 22,300 24,200 8,700 5,900 5,600 2,100 1,000 1,000 1,000    800 
J01F Macrolides 10,100 9,300 10,900 12,900 11,400 7,600 7,100 8,700 11,100b 14,300 
 + lincosamides 
J01G Aminoglycosides 7,800 7,400 7,700 8,500 8,600 7,100 7,800 7,500 10,400 11,900 
J01M/J01X Others  13,800 6,900 6,700 6,800 4,400 600 650 350 4,500  5,200 
J01 Total 64,800 58,400 53,400 73,200 89,900 48,000 57,300 61,900 80,600 94,200 
Source: Data for 1986–94 are from the Federation of Danish Pig Producers and Slaughterhouses: Use of Antibiotics in the Pig Production, edited by N.E. Rønn. Data for 
1996–2000 come from DANMAP 2000 (DVI 2001). 
aTaken from DANMAP 2001 (DVI 2002). 
bAdjusted from DANMAP 2001 (DVI 2002). 
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Source: DANMAP 2000 (DVI 2001); DANMAP 2001 (DVI 2002). 
FIGURE 2. Trends in resistance to selected antimicrobials among isolates from 
domestically acquired human cases in Denmark 
 
phased out were active against gram negative bacteria and could not have created 
resistance in gram positive bacteria such as salmonella or campylobacter. Because of the 
health problems that were encountered, many antimicrobials in use before the ban were 
replaced with tetracyclines, which are active against gram positive bacteria. Tetracycline 
use in Denmark went from 12,100 kg in 1998 to 27,900 kg in 2001, and now Denmark 
has experienced problems with tetracycline resistance in humans. The link between 
animal use of antibiotics and human resistance has not been proven, so we cannot 
conclude that the large increase in the use of human drugs caused a problem. However, it 
is ironic that the policy resulted in an increase in the use of the products about which 
humans are most concerned. 
 
Cost Impacts 
Based on what we learned in Denmark and on an earlier publication that measured the 
costs associated with a previous Swedish ban, we calculated the components of the cost of 
the ban, as shown in Table 2. (Details on these cost estimates are available from the authors). 
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TABLE 2. Productivity impacts in Denmark and Sweden 
 Sweden Denmark 
Age at weaning + 1 week a 
Days from weaning to reach 25 kg + 5 days a 
Feed efficiency from 50 to 250 lbs - 1.5%  -1.5% 
Piglet mortality + 1.5% pts a 
Fattening-finish mortality + 0.04% +0.04 
Piglets per sow - 4.82% -4.82% 
Veterinary and therapeutic costs (per pig) 
net of costs for feed-grade antibiotics 
    + $0.25   
Lawsonia vaccine  $0.75 
a These costs totaled $1.25 per animal in Denmark and were not broken down into specific productivity impacts. 
 
In addition, we included sort-loss costs of $0.64 per animal. Although the Swedish 
and Danish producers did not have a problem with sort loss, this was because the 
producers were able to convince the packers to accept more lightweight pigs. We 
included the sort loss in the costs expected in the United States because of increased 
variability of weights expected with the move away from AGPs and the penalty packers 
place on the lighter-weight pigs. We also include capital costs of $63 million for the 
additional space needed for the extra five days post-weaning, and we include $166 
million for the additional sow space.  
The economic impact of a U.S. ban would depend to a large extent on the willingness 
of U.S. veterinarians to increase therapeutic use. Our best estimate is that costs would 
increase by approximately $4.50 per animal in the first year. The estimated cost increase 
includes an increase in costs at the finishing stage of $1.05 per animal; an increase in costs 
at the weaning stage of $1.25 per animal; an additional veterinary cost of $0.25 per animal; 
a vaccine cost of $0.75 per animal; an increase in sort loss of $0.65 per animal; and a 
capital cost of about $0.55 per animal. Industry profits would be lower than would 
otherwise be the case as U.S. producers adjust to the ban. The total cost of a ban to the U.S 
pork industry spread across a ten-year period is estimated to be in excess of $700 million. 
The expected cost to consumers is an approximate 2 percent increase in retail prices. 
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Economic Effects 
Adding the effects from estimated changes in productivity (Table 2) to the sort loss 
and initial construction costs suggests a first-year impact of $4.50 per head due to the 
effects of a ban on AGPs, which represents a production cost increase of approximately 
4.5 percent. This cost increases slightly as more buildings are required in subsequent 
years and there are fewer animals but the same fixed costs. (For further details on how 
this model is constructed, see Hayes et al. 2001.) Another comparable estimate for the 
United States is a cost of $2.76 per hog (Brorsen et al. 2002); and, a recent estimate of the 
cost in Denmark of the restricted use is $4 per pig (Jensen 2003). These estimates suggest 
the costs are likely to range from $3 to $4.50 per pig.  
As costs increase, production declines, and some producers likely would be forced 
out of business. A lower level of production increases wholesale and retail prices, and 
higher prices help offset some of the cost increases. The profit impact is greatest in year 
one. By year two, the consumer is paying for most of the cost increase, and producer 
profits would fall. The end result is a slightly smaller U.S. pork industry, as slightly 
higher retail prices would result in lower consumption. Our estimates show, by adding up 
the lower profits per animal for all ten years and summing across the entire industry, that 
the total cost of a ban would likely exceed $700 million. The productivity decline 
associated with the ban would be recovered by normal technological advances, but the 
dollars lost to individual producers during the adjustment phase would be not be 
recovered. 
One important lesson from the Danish experience is that there is wide variation in 
the effects incurred among producers. Our results show the economic impacts of a ban on 
an “average” or “representative” farm. These results mask wide differences across farms, 
and these distributional effects are not estimated in the model. With a ban on AGP use, an 
all-in, all-out system is necessary in order to reduce the pressure of infectious diseases. In 
the United States today, as much as 20 percent of production still originates on farms that 
have not yet adopted all-in, all-out processes (Lawrence 2003). Producers who use a 
mixed or continuous-flow system might be disinclined to invest in system changes, and 
thus they would exit the business. Another major factor to consider is that a ban would 
likely increase lightweight pigs. The model accounted for this change as a discount to 
Lessons from the Danish Ban on Feed-Grade Antibiotics / 9 
 
 
producers as they sell on the price grid. In contrast, the Swedish and Danish industries 
own their packers, and therefore the market for the smaller animals is more protected. 
The Danish experience clearly illustrates the differences between the effects of a ban 
at the weaning stage and one implemented at the finishing stage. Our conclusion, based 
on our assessment of the likely effects of a ban on AGP use in U.S. pork production, is 
that a ban at the finishing stage would create very few animal health concerns, but it 
would lead to a slight reduction in feed efficiency and increase the weight spread of 
finished animals. A ban at the weaning stage would create some serious animal health 
concerns and lead to a significant increase in mortality. Faced with these problems, U.S. 
veterinarians would likely resort to more powerful therapeutic antibiotics, and the total 
use of antibiotics could rise, much as has happened in Denmark in the period 
immediately after the ban at the weaning stage. The economic impact of a U.S. ban 
would depend to a large extent on the willingness of U.S. veterinarians to increase 
therapeutic use, and the analysis assumes some increase in veterinary costs and vaccines. 
Recent experience in the United Kingdom indicates that the costs and management of 
eliminating use of subtherapeutic antibiotics are significant. Under agreements with 
retailers, the U.K. producers eliminated AGPs in poultry production in 2000, but now, 
faced with significant problems of disease and diarrhea in their flocks, they are 
reintroducing antibiotics to prevent disease. Currently, total antibiotic use has dropped, 
although AGPs may now be used as one tool in increased management of animal health. 
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